K Pharma (TSE:4896) Short-Term Debt : 円0 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is K Pharma Short-Term Debt?

K Pharma's Short-Term Debt for the quarter that ended in Mar. 2024 was 円0 Mil.

K Pharma Short-Term Debt Historical Data

The historical data trend for K Pharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Short-Term Debt Chart

K Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Short-Term Debt

K Pharma Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial			-	-	-	-	-

K Pharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

K Pharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of K Pharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

K Pharma (TSE:4896) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032

Website

https://en.kpharma.co.jp

K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines